US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 2.075
  • +0.035+1.72%
Trading Mar 28 10:01 ET
527.25MMarket Cap-2231P/E (TTM)

About Lyell Immunopharma Company

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

Company Profile

SymbolLYEL
Company NameLyell Immunopharma
Listing Date06/17/2021
Issue Price17.00
Founded2018
CEODr. Lynn Seely,M.D.
MarketNASDAQ
Employees224
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address201 Haskins Way
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-695-0677

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lynn Seely,M.D.
  • Director, President and Chief Executive Officer
  • 304.22K
  • Charles Newton
  • Chief Financial Officer and Principal Accounting Officer
  • 3.88M
  • Stephen Hill
  • Chief Operating Officer
  • 4.07M
  • Dr. Tina Albertson, M.D.
  • Chief Medical Officer and Head of Development
  • --
  • Dr. Richard Goold, PhD
  • Chief Information Officer
  • --
  • Lisa Ryan
  • Chief People Officer
  • --
  • Dr. Gary Lee, PhD
  • Chief Scientific Officer
  • 4.13M
  • Richard D. Klausner
  • Chairman of the Board
  • 329.22K
  • Catherine J. Friedman
  • Lead Independent Director
  • 348.72K
  • Robert Taylor Nelsen
  • Independent Director
  • 305.22K
  • Dr. Otis W. Brawley,M.D.
  • Independent Director
  • 313.59K
  • William J. Rieflin
  • Independent Director
  • 320.48K
  • Hans Edgar Bishop
  • Independent Director
  • 304.22K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 308.87K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg